表紙
市場調查報告書

手術用黏劑的全球市場:2020年∼2027年

Global Surgical Glue Market - 2020-2027

出版商 DataM Intelligence 商品編碼 955732
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
手術用黏劑的全球市場:2020年∼2027年 Global Surgical Glue Market - 2020-2027
出版日期: 2020年08月31日內容資訊: 英文
簡介

手術用黏劑 (又稱外科用密封膠或黏劑),是為了結合外部或內部組織,用於手術或外傷後。手術用黏劑,結合縫合線和釘針,或可做替代使用。使用化學結合將組織保持在一起以進行癒合,或充當阻止體液流動的屏障。

本報告提供全球手術用黏劑市場相關調查分析,產業分析,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 全球手術用黏劑市場調查手法和範圍

第2章 全球手術用黏劑市場:市場定義和概要

第3章 全球手術用黏劑市場:摘要整理

第4章 全球手術用黏劑市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 手術用黏劑相關的副作用
  • 影響分析
  • 機會

第5章 全球手術用黏劑市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 法規分析
  • 價格分析
  • 產品分析
  • 售後服務分析

第6章 全球手術用黏劑市場:各產品類型

  • 簡介
  • 市場規模分析、與前一年同期比較成長分析:各產品類型
  • 市場魅力指數:各產品類型
    • 骨內植入
    • 骨膜下植入
    • 骨貫通植入
    • 粘膜內植入

第7章 全球手術用黏劑市場:各用途

  • 簡介
  • 市場規模分析、與前一年同期比較成長分析:各用途
  • 市場魅力指數:各用途
    • 鈦植入
    • 鋯植入
    • 陶瓷植入
    • 金屬植入融合的陶材

第8章 全球手術用黏劑市場:各終端用戶

  • 簡介
  • 市場規模分析、與前一年同期比較成長分析:各終端用戶
  • 市場魅力指數:各終端用戶
    • 醫院
    • 牙科診所
    • 學術、研究機關

第9章 全球手術用黏劑市場:各地區

  • 簡介
  • 市場規模分析、與前一年同期比較成長分析:各地區
  • 市場魅力指數:各地區
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第10章 全球手術用黏劑市場競爭情形

  • 競爭模式
  • 市場定位/佔有率分析
  • M&A分析

第11章 全球手術用黏劑市場企業簡介

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Advanced Medical Solutions Group PLC
  • C. R. Bard Inc
  • Cardinal Health Inc.
  • CryoLife Inc.
  • Integra LifeSciences Holdings Corporation
  • Cohera Medical Inc.
  • Takeda Pharmaceutical Company Limited.
  • Medtronic PLC.等

第12章 全球手術用黏劑市場:重要考察

第13章 全球手術用黏劑市場:DataM

目錄

Market Overview

Surgical glues (also called surgical sealants or adhesives) are used after a surgery or traumatic injury to bind together external or internal tissue. Surgical glues can be used in conjunction with or as an alternative to sutures and staples; they use a chemical bond to hold tissue together for healing or serve as a barrier to stop the flow of bodily fluids.

Advancements in the surgical glue market were primarily aimed at addressing the limitations of traditional wound sealing techniques. Furthermore, due to favorable biological and physical properties of surgical glue, more number of surgeons are using this technique to seal wounds. Surgical glue is derived from several natural biopolymers including gelatin, collagen, chitosan, albumin, and fibrin.

Market Dynamics:

The market is driven is the rising number of traumatic injuries. The market growth is also majorly driven by the rise in the number of surgical procedures and burn cases, along with increasing incidences of road accidents, globally. The rising health awareness and high prevalence of the diseases (such as skin diseases, cancer, heart diseases, and respiratory diseases) have increased the opportunities for the surgeries.

According to the World Health Organization (WHO) 2020 report, estimates approximately 1.35 million people die each year as a result of road traffic crashes. 20 to 50 million people suffer from non-fatal injuries, with many incurring a disability as a result of their injury. 93% of the world's fatalities on the roads occur in low and middle-income countries, even though these countries have approximately 60% of the world's vehicles. Even within high-income countries, individuals from lower socioeconomic backgrounds are more likely to be involved in road traffic crashes. Thus, rising prevalence of diseases along with road injury cases is expected to drive the market.

Additionally, there are innumerable accessibility and availability of these devices across the globe, which is one the major reason that is pertaining towards the growth of surgical glue market. It has been observed that the citizens of both developed, as well as developing countries, are extensively spending on healthcare services due to the increasing disposable income of the residents of those countries and increasing issues regarding health.

According to a recent study published by Centers for Disease Control and Prevention (CDC) it has been established that the total expenditure on healthcare services in the U.S. has projected towards a total of $3.9 trillion. Moreover, according to a report furnished by the U.K. Office for National Statistics (ONS), U.K.'s total healthcare expenditure accounted for approximately $300 billion in the recent past.

Abovementioned data indicate that countries are increasingly spending on healthcare and related facilities owing to rising medical awareness, growth in disposable income, and various developments in surgical facilities. Thus, patients suffering from various diseases are going for surgeries (better and quick treatment options), which, in turn, is driving the global surgical glue market growth.

Surgical glue has several limitations associated with its usability and safety, such as allergic reactions, wound dehiscence, and skin infections. In addition, it is categorized as class II by the FDA and class B by the Drugs and Cosmetics Acts (1940) in India, which makes it a little risky and thus requiring clinical trials and further leading to legal complexities. The safety, quality, and performance of these materials are necessary facets requiring stringent evaluation for public health, which lead to complex and strict regulations for their affiliation. Therefore, these factors are hampering the growth of the surgical glue market.

Segment Analysis

The global dental implants market is segmented based on product by fibrin, collagen, gelatin, cyanoacrylate, polymeric hydrogel, and urethane-based adhesive. The cyanoacrylates segment held the largest market share. Cyanoacrylate is a sticky substance found in many glues. Cyanoacrylate poisoning occurs when someone swallows this substance or gets it on their skin. Once the applicator is initiated and the cyanoacrylate adhesive is applied to moist tissue the polymerization process occurs. A feature of our cyanoacrylate devices is that only a low level of heat is generated when this polymerization starts, consequently the patient does not experience the stinging or burning sensation that occurs with some competitor products.

Cyanoacrylate glue are biocompatible and do not need removal as they naturally slough off the skin as part of the natural wound healing process. The properties of cyanoacrylate, namely fast-setting, high tensile strength polymers that bind with the skins surface and are flexible, durable, waterproof and transparent on setting, make cyanoacrylate ideal for wound closure and skin barrier products. Cyanoacrylates provide a non-traumatic means of wound closure and can provide an enhanced patient experience over conventional wound closure methods. They are commonly used to close laparoscopic incisions and are much stronger than fibrin sealants and sutures. Cyanoacrylates are waterproof, flexible and require no dressing on the wound.

The Fibrin glue segment is expected to have positive market growth in the forecast period. Fibrin glue are a type of surgical adhesive derived from both human and animal (bovine) blood products. Ingredients in the fibrin sealant interact during application to form a clot made from the blood protein called fibrin. Fibrin sealants are effective for use in cardiovascular surgery, lung surgery and closure of the Dural (a fibrous membrane covering the brain and spinal cord) and can be used to close spleen and liver lacerations.

Fibrin sealant is additionally used in hemostasis processes in order to control bleeding during and after surgical procedure, which is one of the leading fibrin sealants market trends. Fibrin sealant comprises of fibrinogen and thrombin which plays a vital role in hemostasis process during severe bleeding. . Fibrin sealant is the only commercially available FDA-approved material for clinical use as a hemostat, sealant, and adhesive. Fibrin sealants are referred as most adopted hemostats worldwide.

Further, the market is also classified based on application as cardiovascular surgery, orthopedic surgery, general surgery, cosmetic surgery, pulmonary surgery, central nervous system surgery, other. The cardiovascular surgery segment is held the largest market share. Rise in incidence of diseases correspondingly drives the number of surgical procedures performed, thereby, boosting the usage of surgical glues in surgeries and mainly, cardiovascular procedures globally. It has been a standard procedure in most medical centers providing surgical services for several years. Both the range and the number of surgical procedures performed are constantly increasing, which is driving the segment.

The globally increasing aging population is one of the major drivers of this segment. According to WHO, the world's geriatric population is expected to nearly double from 12.0% to 22.0% between 2015 and 2050. The market is expected to be driven by a vascular malfunction in the geriatric population and a rise in congenital defects. Furthermore, physical inactivity and an unhealthy lifestyle are also increasing the incidence of cardiovascular conditions.

According to the American Heart Association Research, cardiovascular diseases accounted for more than 8 lakh deaths in the U.S. in 2016. It has been observed that these diseases claim more lives than chronic lower respiratory disease and cancer combined. Approximately 2,300 Americans die due to cardiovascular diseases each day, an average of one death every 38 seconds. This factor will drive the growth of the segment.

The cosmetic surgery segment is expected to have positive market growth in the forecast period. This is due to the increasing adoption of surgical glue for cosmetic procedures and burn treatment surgeries. It is further set to increase with the increasing number of facial cosmetic surgeries, increasing cases of skin injuries, growing incidence of burn injuries, and an increasing number of breast cancer patients undergoing mastectomy and breast reconstruction procedures across the globe. This factor will drive the growth of the market in the forecast period.

Geographical Presentation

By region, the global dental implants market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global surgical glue market and is expected to grow at the highest CAGR during the forecast period. North America is anticipated to continue being the largest-growing surgical glue market in the coming years. The factors that have contributed to the growth include the increasing investments in R&D of medical adhesives and their several applications in different surgeries performed in the region. As per Heart Disease & Stroke Statistical Fact Sheet 2020, estimates that a minimum of 40,000 infants is expected to be affected each year by congenital heart defects in the United States. Of these, about 25% or 2.4 (per 1,000 live births), require treatment in the first year of life. Moreover, the increasing demand for and focus on cosmetic surgery, as well as its growing awareness of preventative and corrective treatment in the USA is driving the growth of the market in this region.

The Asia-Pacific region is expected to have third-largest share due to presence of a large patient pool, availability of skilled technicians at a comparatively lower price, and a defined regulatory framework favoring expedited product approvals. Furthermore, the booming medical tourism industry in countries such as India, China, and Malaysia are expected to boost demand for surgical glue.

Competitive Analysis

The global surgical glue market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition B. Braun Melsungen AG, Baxter International Inc., Advanced Medical Solutions Group PLC, C. R. Bard Inc., Cardinal Health Inc., CryoLife Inc., Integra LifeSciences Holdings Corporation, Cohera Medical Inc., Takeda Pharmaceutical Company Limited., and Johnson & Johnson, Medtronic PLC. are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market.

The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to expand their presence and meet the rising demand for the surgical glue across the globe. For instance,

  • In March 2018, Baxter has completed the acquisition of Recothrom and Preveleak to broaden its surgical portfolio.
  • In June 2019, the research team at Technion - Israel Institute of Technology, announced that they have developed a new surgical glue that is non-toxic, biodegradable, and flexible. The new product is compatible with both internal as well as external surgeries. Despite emerging as a reliable alternative for surgical staplers and sutures, surgical glue is typically used for external applications only.

Why Purchase the Report?

  • Visualize the composition of the global surgical glue market products in terms of product type, application and end-user and highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the global surgical glue market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global surgical glue market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

*The global surgical glue market report will provide access to approximately 61 market data tables, 46 figures, and 200 pages.

Target Audience

  • Industry Investors/Investment Bankers
  • Suppliers/Buyers
  • Education & Research Institutes
  • Manufacturers
  • Research Professionals
  • Emerging Companies
  • Distributors

Table of Contents

1. Global Surgical Glue Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Surgical Glue Market - Market Definition and Overview

3. Global Surgical Glue Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Global Surgical Glue Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Incidences of Road Accidents
      • 4.1.1.2. Growing Number of Surgical Procedures
    • 4.1.2. Restraints
    • 4.1.3. Side Effects Associated with Surgical Glue
  • 4.2. Impact Analysis
  • 4.3. Opportunity

5. Global Surgical Glue Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Product Analysis
  • 5.6. Post Sales Services Analysis

6. Global Surgical Glue Market - By Product Type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 6.3. Market Attractiveness Index, By Product Type
    • 6.3.1. Endosteal Implants *
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
    • 6.3.2. Subperiosteal Implants
    • 6.3.3. Transosteal Implants
    • 6.3.4. Intramucosal Implants

7. Global Surgical Glue Market - By Application

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 7.3. Market Attractiveness Index, By Application
    • 7.3.1. Titanium Implants*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
    • 7.3.2. Zirconium Implants
    • 7.3.3. Ceramic Implants
    • 7.3.4. Porcelain Fused To Metal Implant

8. Global Surgical Glue Market - By End-User

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 8.3. Market Attractiveness Index, By End-User
    • 8.3.1. Hospitals*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
    • 8.3.2. Dental Clinics
    • 8.3.3. Academic & Research Institutes

9. Global Surgical Glue Market - By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. U.S.
      • 9.4.6.2. Canada
      • 9.4.6.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. Germany
      • 9.5.6.2. U.K.
      • 9.5.6.3. France
      • 9.5.6.4. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.6.1. Brazil
      • 9.6.6.2. Argentina
      • 9.6.6.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.6.1. China
      • 9.7.6.2. India
      • 9.7.6.3. Japan
      • 9.7.6.4. Australia
      • 9.7.6.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Global Surgical Glue Market Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Global Surgical Glue Market Company Profiles

  • 11.1. B. Braun Melsungen AG*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Developments
    • 11.1.4. Financial Overview
  • 11.2. Baxter International Inc.
  • 11.3. Advanced Medical Solutions Group PLC
  • 11.4. C. R. Bard Inc
  • 11.5. Cardinal Health Inc.
  • 11.6. CryoLife Inc.
  • 11.7. Integra LifeSciences Holdings Corporation
  • 11.8. Cohera Medical Inc.
  • 11.9. Takeda Pharmaceutical Company Limited.
  • 11.10. Medtronic PLC.
  • List is not exhaustive

12. Global Surgical Glue Market - Premium Insights

13. Global Surgical Glue Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us